MedTrace Logo

Double J Stenting and Sildosin After URSL for Lower Ureteric Stones

NCT05823662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-04-24

No results posted yet for this study

Summary

The aim of this prospective comparative clinical study to compare DJ stenting and Sildosin after ureteroscopic lithotripsy for lower ureteric stones.

Conditions

  • Lower Ureteric Stones
  • Ureteroscopic Lithotripsy
  • DJ Stenting

Interventions

PROCEDURE

DJ stent

A 5 Fr DJ stent will be inserted and then removed after three weeks.

DRUG

Silodosin

Patients will be given one capsule of silodosin 8 mg at the night for three weeks.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-02
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05823662 on ClinicalTrials.gov